PDS Biotechnology logo

PDS Biotechnology

PDSB | NASDAQ
Chart Builder DCF Calculator
$0.92
+$0.05 (+5.43%)
At close: Nov 16, 2026, 4:00 PM ET
$0.91
-$0.01 (-0.67%)
After-hours: Nov 16, 2026, 7:48 PM ET
+5.43%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
32.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #742/1021 (Top 73%)

Key Statistics

Market Data

Market Cap $66.18M
1D Range
0.81 0.97
52W Range
0.20 1.60

Valuation (TTM)

PE -1.64
PB -18.49
EV/EBITDA -2.58

Valuation (NTM)

Forward PE N/A
Forward PEG 0.03
Price Target $4.00
Loading financial charts...

Profile

PDS Biotechnology Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing innovative, multi-functional immunotherapies to combat cancer. Its primary drug candidate, PDS0101 (HPV1...

Sector Healthcare
Industry Biotechnology
Employees 21
IPO Date Sep 30, 2015
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$4.00
Upside
+334.78%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.